Mark Doerr

Mark Doerr is a principal and senior research analyst at Tech Insider covering medical technology companies with a focus on cardiovascular and related therapeutic technology. Mark leverages his prior experience as the director of marketing and business development at a medical device company, along with an extensive network of physician and industry relationships, to provide a unique perspective on the medtech sector. Prior to joining Tech Insider in 2011 he covered medical technology for four years at Craig-Hallum Capital, and has in total 20 years of financial and medtech industry experience.

Healthcare Bullish Stocks: Biocept Inc (NASDAQ:BIOC), Rosetta Genomics (NASDAQ:ROSG), Cryolife (NYSE:CRY), Telik (NASDAQ:TELK)

Shares of Biocept Inc (NASDAQ:BIOC) have been volatile since the company made its debut as a public company in early February. In an exclusive interview with Benzinga, CEO Michael Nall and CFO Bill Kachioff laid out the company’s opportunities and events investors should watch for in the near future. Biocept is a cancer diagnostics company…

Read More

Healthcare Decliners: Sorrento Therapeutics (NASDAQ:SRNE), Fibrocell Science (NYSEMKT:FCSC), TG Therapeutics (NASDAQ:TGTX), CombiMatrix (NASDAQ:CBMX)

Sorrento Therapeutics Inc (NASDAQ:SRNE) announced in a press release that the National Institutes of Health (NIH) has provided funding for the development of bispecific antibodies. Two small business grants from the NIH will allow Sorrento to use its antibody conjugation technology platform to develop antibodies for two of the NIH’s anti-bacterial immunotherapies. Sorrento’s pipeline also…

Read More

Recent Insider Buying: American Realty Capital Properties (NASDAQ:ARCP), MannKind (NASDAQ:MNKD), Republic Services (NYSE:RSG), American Apparel (NYSEMKT:APP)

William Stanley, Director at American Realty Capital Properties Inc. (NASDAQ:ARCP), bought 18,000 shares of Common Stock on 25 June, paying a price of $12.39 per share. American Realty Capital Properties Inc (NASDAQ:ARCP) stock performance was 0.24% in last session and finished the day at $12.44. Traded volume was 5.47million shares in the last session and…

Read More

Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of hepatocellular carcinoma (HCC). CASI Pharmaceuticals Inc (NASDAQ:CASI) stock performance was…

Read More

Top Gainers: TherapeuticsMD (NYSEMKT:TXMD), Neurometrix (NASDAQ:NURO), Bioamber (NYSE:BIOA), Digital Power Corporation (NYSEMKT:DPW)

In company news, TherapeuticsMD Inc. (NYSEMKT:TXMD) rallied Tuesday after analysts at FBR Capital today initiated coverage of the women’s healthcare company with an Outperform rating. TherapeuticsMD Inc (NYSEMKT:TXMD) stock performance was 32.45% in last session and finished the day at $5.47. Traded volume was 23.15million shares in the last session and the average volume of…

Read More

Consumer Goods Active Movers: Tesla Motors Inc (NASDAQ:TSLA), Apple Inc. (NASDAQ:AAPL), Coca-Cola Company (NYSE:KO), Procter & Gamble (NYSE:PG)

Tesla Motors Inc. (NASDAQ:TSLA) was sued in China for trademark infringement in the latest example of the difficulties foreign companies face doing business in the country. Tesla Motors Inc (NASDAQ:TSLA) stock performance was -2.87% in last session and finished the day at $222.66. Traded volume was 5.89million shares in the last session and the average…

Read More
Home